MARGARET CONSTANTE: Open Payments
NPI 1457313900 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 55 payments from 14 companies in 2025. Trend: 2023 $1,457 · 2024 $1,973 · 2025 $1,512
Food & beverage: $1,348Education: $164
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $415 |
| Organon LLC | 7 | $325 |
| UCB, Inc. | 6 | $178 |
| Novartis Pharmaceuticals Corporation | 6 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $117 |
| GENZYME CORPORATION | 2 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| ABBVIE INC. | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
Products named: TREMFYA, VTAMA, Bimzelx, DUPIXENT, COSENTYX, Winlevi, ILUMYA, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
